THE June edition of Australian Prescriber has a few three- to four-minute reads summarising five new drugs in Australia: guanfacine hydrochloride for attention deficit hyperactivity disorder, atezolizumab for non-small cell lung cancer, ocrelizumab for multiple sclerosis, palbociclib for breast cancer and silodosin for benign prostatic hypertrophy.
Access at nps.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jul 18
